Envestnet Asset Management
CLDX icon

Envestnet Asset Management’s Celldex Therapeutics CLDX Stock Holding History

Envestnet Asset Management’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.05M Sell
33,053
-16,023
-33% -$437K ﹤0.01% 3447
2025
Q4 		$1.33M Sell
49,076
-14,518
-23% -$382K ﹤0.01% 3113
2025
Q3 		$1.65M Buy
63,594
+21,307
+50% +$494K ﹤0.01% 3009
2025
Q2 		$861K Buy
+42,287
New +$823K ﹤0.01% 3363
2014
Q4 		– Sell
-2
Closed – – 2527
2014
Q3 		$0 Hold
2
– – ﹤0.01% 2756
2014
Q2 		$0 Hold
2
– – ﹤0.01% 2713
2014
Q1 		$0 Hold
2
– – ﹤0.01% 2557
2013
Q4 		$1K Buy
+2
New +$770 ﹤0.01% 2328

Other funds holding CLDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EP
Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return